- No public price. Vendor page says it is "competitively priced" with no tiers. Free and individual accounts must not be used with PHI; BAA only for organizational accounts.
- Not disclosed
- Not disclosed
- —
- 2017
- US


Clair
by CareTria · founded 2017 · US
Clinical AI reference for clinicians with drug interactions, antibiotic stewardship and answers that cite their sources.
On this page
Editorial rating 2.5 / 5
- Clinical Integration0/6.6
No EHR integrations listed
- Evidence Strength11.4/27
1 peer-reviewed paper
- Vendor & Market9.9/21.6
Founded 2017 (9 years)
- Sentiment & Transparency0/6
No public pricing
▸ Show all 11 dimensions▾ Hide dimension detail
- EHR integrations (count)0/4
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/2
None of the top-3 EHRs covered
- Peer-reviewed papers8/21
1 peer-reviewed paper
- RCT / meta-analysis / systematic review3/6
1 observational study (no RCT)
- Funding & adoption signal4/16
Seed-stage or unfunded
- Years in market6/6
Founded 2017 (9 years)
- Pricing transparency0/6
No public pricing
Clinical AI reference for clinicians with drug interactions, antibiotic stewardship and answers that cite their sources.
No public price. Vendor page says it is "competitively priced" with no tiers. Free and individual accounts must not be used with PHI; BAA only for organizational accounts.
Evidence record
1 study on PubMed: 1 observational, published 2026. Read the literature summary
- Score computed November 2, 2026, method 1.2.0
- Review written November 2, 2026
MedAI Verdict, Clair record, https://medaiverdict.com/tools/caryhealth-clair, version November 2, 2026
Bottom line
Clair is a clinical question tool that its vendor calls "Your clinical AI reference". A clinician types a question or picks a function such as drug interactions or antibiotic stewardship, and the vendor says every answer carries references. CaryHealth's homepage says it is now CareTria, and its About page lists the headline "CareTria Acquires CaryHealth" with no date. An individual pharmacist or physician asking general questions fits the free account. A hospital that wants patient information anywhere near Clair needs an organizational account with a BAA, because the free and individual tiers are not for PHI.
What can a clinician ask Clair?
Open Search takes a natural-language clinical question. Clinical Summary gives a guided summary of any disease or drug, and Drug Interactions takes two or more drugs. Stewardship suggests treatment, dose and duration by infection type, with optional demographics. ICD10 Codes gives plain-language definitions, Med Review offers "evidence-based recommendations for patient care", and My Documents Search lets a user upload their own protocols. The vendor page calls Clair "purpose-built for healthcare", and the enterprise page mentions custom AI guardrails and white-label branding.
The vendor lists 200M+ clinical studies, 2M+ drug interactions, 147K+ FDA package inserts and 100+ clinical guidelines among its sources. It does not name the language model behind Clair. It lists iOS and Android apps, and says Clair integrates into EHR systems and offers an API, without naming an EHR vendor. A line on askclair.ai, "Cuts down search time by 90%", cites no study.
Who sells it after the acquisition?
CareTria, Inc. gives its corporate address as One Healthcare Way, Lakewood, New Jersey. The product site askclair.ai still carries a 2026 footer and links to CaryHealth's legal pages. The acquisition date, its terms and the legal entity behind askclair.ai are not stated.
CaryHealth began in 2017 as CaryRx, founded by Areo Nazari (CEO) and Kevin Lance (COO). Its About page says it was founded in DC, and a PubMed paper lists the affiliation "CaryHealth, Washington, DC". The vendor states no funding.
Can patient information go in, and what does it cost?
The consent dialog on askclair.ai tells users "do not include any PHI or PII" and points to an organizational account with a BAA. The vendor publishes a Notice of Privacy Practices and lists no SOC 2, HITRUST, ISO 27001 or GDPR attestation for Clair. The Clair page claims no FDA clearance.
CaryHealth calls Clair "competitively priced" and gives no tiers, currency or billing period. The askclair.ai pages offer "Sign up for Free" and "Sign up for full access" with neither limits nor prices shown.
What did the independent test find?
Ipema and colleagues at the University of Illinois Chicago (J Am Coll Clin Pharm, 2026, PMID 42203638) put 30 drug-information questions to OpenEvidence, Clair, GlassHealth, DougallGPT and ChatGPT. Three pharmacy faculty scored the answers on the 25-point CLEAR scale. The abstract reports the top two scores, OpenEvidence at 17.82 and ChatGPT at 15.72, and does not report Clair's own score. Every chatbot scored statistically below the faculty, and "evidence supporting the content" was the weakest component. The authors conclude that "Pharmacist expertise remains essential". The study is academic and not vendor-authored.
The verdict
An individual clinician with general questions fits the free tier. A clinician who wants to enter patient details is told by the consent dialog to use an organizational account, which comes with a BAA, and the vendor publishes no compliance statement for Clair itself. The same dialog calls Clair "an informational tool intended for medical professionals only".
Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. Vendor page says it is "competitively priced" with no tiers. Free and individual accounts must not be used with PHI; BAA only for organizational accounts. |
Source: vendor pricing page. Last checked November 2, 2026.
Who builds it
Clair (CareTria) was founded in 2017 in US, putting it 9 years into market. It was previously known as CaryHealth, an acquisition or rebrand that healthcare-AI buyers should track when reviewing prior independent coverage.
What the literature says
1 peer-reviewed study indexed on PubMed evaluate Clair in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.
- Evaluation of Clinically-Focused Artificial Intelligence Chatbots for Answering Drug Information Questions. (opens in new tab)
- Ipema H, Munir F, Sarna K, et al.· J Am Coll Clin Pharm· 2026
- Artificial intelligence (AI) tools are increasingly promoted for clinical decision support in health care. While studies have assessed general-purpose AI chatbots on the accuracy and quality of clinical or drug-related questions, direct comparison among multiple clinically-focused AI chatbots is lacking. This study compared the quality of responses to drug information (DI) questions from multiple clinically-focused AI chatbots with responses from DI pharmacists. Thirty DI questions previously answered by DI pharmacy faculty were queried in four clinically-focused AI chatbots: OpenEvidence (Op…


